Faeth names Karen Vousden as class II director
Faeth Therapeutics appointed Karen Vousden, Ph.D. as a Class II director and added her to the Compensation Committee, effective September 11, 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.